Eternal Peptides
Eternal Peptides' purity-focus record is strongest for Melanotan II, while Retatrutide is mixed with a later improvement. The weaker side is repeated sub-99.5% purity for BPC-157 and Semaglutide, so results are dispersed rather than uniform; evidence is recent overall, but several signals lean on narrow batch clusters.
NY filings, trademark records and the terms page tie Eternal Peptides to Cenvira LLC and named applicants, while the domain timeline leaves a launch-channel gap. The report also maps coded GLP products, restored card rails, exposed COA-page controls and promo-code activity.
Unlock original COAs
View and download original lab PDFs for Finnrick tests, including Eternal Peptides rows.
Cancel anytime
| Date | Result | Test | Lab | Purity | Dosage | Label | COA |
|---|---|---|---|---|---|---|---|
| 14 Jul 2026 | Pass | Tirzepatide Eternal Peptides | lab name | View COA | |||
| 25 Mar 2026 | Pass | Retatrutide Eternal Peptides | lab name | View COA | |||
| 19 Mar 2026 | Fail | BPC-157 Eternal Peptides | lab name | View COA | |||
| 10 Mar 2026 | Fail | BPC-157 Eternal Peptides | lab name | View COA | |||
| 17 Nov 2025 | Fail | BPC-157 Eternal Peptides | lab name | View COA | |||
| 21 May 2025 | Fail | Retatrutide Eternal Peptides | lab name | View COA | |||
| 21 May 2025 | Pass | Melanotan II Eternal Peptides | lab name | View COA | |||
| 21 May 2025 | Fail | Retatrutide Eternal Peptides | lab name | View COA | |||
| 21 May 2025 | Fail | Semaglutide Eternal Peptides | lab name | View COA | |||
| 21 May 2025 | Fail | Tirzepatide Eternal Peptides | lab name | View COA | |||
About Eternal Peptides test results from Finnrick
Eternal Peptides is a peptide vendor tracked in Finnrick's independent testing dataset. This page compiles batch-level results across 5 peptides and 27 tests, including ratings, observed price signals, recent test dates, and correction history where available.
Finnrick ratings are calculated from published sample data using the selected rating standard. The default standard evaluates purity, dose accuracy, and label quality, then adjusts low-volume results so small sample counts do not appear more certain than the data supports.
The most visible Eternal Peptides peptides in this dataset are Melanotan II (4 tests) and Semaglutide (4 tests). Use the peptide table above to compare the current Finnrick rating, price per mg, and sample volume for each peptide.
Recent tests and corrections are shown below when available. Samples may be acquired by Finnrick directly or submitted through Finnrick testing programs; the goal is to make safety and supply-chain evidence easier to evaluate than vendor marketing claims alone. This page currently lists 27 recent tests.